Screening of TACE Peptide Inhibitors from Phage Display Peptide Library
Summary: To obtain the recombinant tumor necrosis factor-α converting enzyme (TACE) ectodomain and use it as a selective molecule for the screening of TACE peptide inhibitors, the cDNA coding catalytic domain (TS00) and full-length ectodomain (T1300) of TACE were amplified by RT-PCR, and the expres....
Saved in:
Published in | Journal of Huazhong University of Science and Technology. Medical sciences Vol. 25; no. 5; pp. 473 - 476 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
China
Department of Biochemistry & Molecular Biology, School of Basic Medical Sciences, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
2005
Wuhan Institute of Medical Sciences,Wuhan 430014,China%Department of Biochemistry & Molecular Biology, School of Basic Medical Sciences, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China |
Subjects | |
Online Access | Get full text |
ISSN | 1672-0733 1993-1352 |
DOI | 10.1007/BF02895991 |
Cover
Abstract | Summary: To obtain the recombinant tumor necrosis factor-α converting enzyme (TACE) ectodomain and use it as a selective molecule for the screening of TACE peptide inhibitors, the cDNA coding catalytic domain (TS00) and full-length ectodomain (T1300) of TACE were amplified by RT-PCR, and the expres.sion plasmids were constructed by inserting T800 and T1300 into plasmid pET-28a and pET-28c respectively. The recombinant TS00 and T1300 were induced by IPTG, and SDS-PAGE and Western blotting analysis results revealed that TS00 and T1300 were highly expressed in the form of inclusion body. After Ni^2+-NTA resin affinity chromatography, the recombinant proreins were used in the screening of TACE-binding peptides from phage display peptide library respectively. After 4 rounds of biopanning, the positive phage clones were analyzed by ELISA, competitive inhibition assay and DNA sequencing. A common amino acid sequence (TRWLVYFSRPYLVAT) was found and synthesized. The synthetic peptide could inhibit the TNF-α release from LPS-stimulated human peripheral blood mononuclear cells (PBMC) up to 60.3%. FACS analysis revealed that the peptide mediated the accumulation of TNF-α on the cell surface. These results demonstrate that the TACE binding peptide is an effective antagonist of TACE. |
---|---|
AbstractList | Summary: To obtain the recombinant tumor necrosis factor-α converting enzyme (TACE) ectodomain and use it as a selective molecule for the screening of TACE peptide inhibitors, the cDNA coding catalytic domain (TS00) and full-length ectodomain (T1300) of TACE were amplified by RT-PCR, and the expres.sion plasmids were constructed by inserting T800 and T1300 into plasmid pET-28a and pET-28c respectively. The recombinant TS00 and T1300 were induced by IPTG, and SDS-PAGE and Western blotting analysis results revealed that TS00 and T1300 were highly expressed in the form of inclusion body. After Ni^2+-NTA resin affinity chromatography, the recombinant proreins were used in the screening of TACE-binding peptides from phage display peptide library respectively. After 4 rounds of biopanning, the positive phage clones were analyzed by ELISA, competitive inhibition assay and DNA sequencing. A common amino acid sequence (TRWLVYFSRPYLVAT) was found and synthesized. The synthetic peptide could inhibit the TNF-α release from LPS-stimulated human peripheral blood mononuclear cells (PBMC) up to 60.3%. FACS analysis revealed that the peptide mediated the accumulation of TNF-α on the cell surface. These results demonstrate that the TACE binding peptide is an effective antagonist of TACE. To obtain the recombinant tumor necrosis factor-alpha converting enzyme (TACE) ectodomain and use it as a selective molecule for the screening of TACE peptide inhibitors, the cDNA coding catalytic domain (T800) and full-length ectodomain (T1300) of TACE were amplified by RT-PCR, and the expression plasmids were constructed by inserting T800 and T1300 into plasmid pET-28a and pET-28c respectively. The recombinant T800 and T1300 were induced by IPTG, and SDS-PAGE and Western blotting analysis results revealed that T800 and T1300 were highly expressed in the form of inclusion body. After Ni(2+)-NTA resin affinity chromatography, the recombinant proteins were used in the screening of TACE-binding peptides from phage display peptide library respectively. After 4 rounds of biopanning, the positive phage clones were analyzed by ELISA, competitive inhibition assay and DNA sequencing. A common amino acid sequence (TRWLVYFSRPYLVAT) was found and synthesized. The synthetic peptide could inhibit the TNF-alpha release from LPS-stimulated human peripheral blood mononuclear cells (PBMC) up to 60.3%. FACS analysis revealed that the peptide mediated the accumulation of TNF-alpha on the cell surface. These results demonstrate that the TACE-binding peptide is an effective antagonist of TACE. To obtain the recombinant tumor necrosis factor-alpha converting enzyme (TACE) ectodomain and use it as a selective molecule for the screening of TACE peptide inhibitors, the cDNA coding catalytic domain (T800) and full-length ectodomain (T1300) of TACE were amplified by RT-PCR, and the expression plasmids were constructed by inserting T800 and T1300 into plasmid pET-28a and pET-28c respectively. The recombinant T800 and T1300 were induced by IPTG, and SDS-PAGE and Western blotting analysis results revealed that T800 and T1300 were highly expressed in the form of inclusion body. After Ni(2+)-NTA resin affinity chromatography, the recombinant proteins were used in the screening of TACE-binding peptides from phage display peptide library respectively. After 4 rounds of biopanning, the positive phage clones were analyzed by ELISA, competitive inhibition assay and DNA sequencing. A common amino acid sequence (TRWLVYFSRPYLVAT) was found and synthesized. The synthetic peptide could inhibit the TNF-alpha release from LPS-stimulated human peripheral blood mononuclear cells (PBMC) up to 60.3%. FACS analysis revealed that the peptide mediated the accumulation of TNF-alpha on the cell surface. These results demonstrate that the TACE-binding peptide is an effective antagonist of TACE.To obtain the recombinant tumor necrosis factor-alpha converting enzyme (TACE) ectodomain and use it as a selective molecule for the screening of TACE peptide inhibitors, the cDNA coding catalytic domain (T800) and full-length ectodomain (T1300) of TACE were amplified by RT-PCR, and the expression plasmids were constructed by inserting T800 and T1300 into plasmid pET-28a and pET-28c respectively. The recombinant T800 and T1300 were induced by IPTG, and SDS-PAGE and Western blotting analysis results revealed that T800 and T1300 were highly expressed in the form of inclusion body. After Ni(2+)-NTA resin affinity chromatography, the recombinant proteins were used in the screening of TACE-binding peptides from phage display peptide library respectively. After 4 rounds of biopanning, the positive phage clones were analyzed by ELISA, competitive inhibition assay and DNA sequencing. A common amino acid sequence (TRWLVYFSRPYLVAT) was found and synthesized. The synthetic peptide could inhibit the TNF-alpha release from LPS-stimulated human peripheral blood mononuclear cells (PBMC) up to 60.3%. FACS analysis revealed that the peptide mediated the accumulation of TNF-alpha on the cell surface. These results demonstrate that the TACE-binding peptide is an effective antagonist of TACE. R4; To obtain the recombinant tumor necrosis factor-α converting enzyme (TACE) ectodomain and use it as a selective molecule for the screening of TACE peptide inhibitors, the cDNA coding catalytic domain (T800) and full-length ectodomain (T1300) of TACE were amplified by RTPCR, and the expression plasmids were constructed by inserting T800 and T1300 into plasmid pET28a and pET-28c respectively. The recombinant T800 and T1300 were induced by IPTG, and SDSPAGE and Western blotting analysis results revealed that T800 and T1300 were highly expressed in the form of inclusion body. After Ni2+-NTA resin affinity chromatography, the recombinant proteins were used in the screening of TACE-binding peptides from phage display peptide library respectively. After 4 rounds of biopanning, the positive phage clones were analyzed by ELISA, competitive inhibition assay and DNA sequencing. A common amino acid sequence (TRWLVYFSRPYLVAT) was found and synthesized. The synthetic peptide could inhibit the TNF-α release from LPS-stimulated human peripheral blood mononuclear cells (PBMC) up to 60.3 %. FACS analysis revealed that the peptide mediated the accumulation of TNF-α on the cell surface. These results demonstrate that the TACE-binding peptide is an effective antagonist of TACE. To obtain the recombinant tumor necrosis factor- alpha converting enzyme (TACE) ectodomain and use it as a selective molecule for the screening of TACE peptide inhibitors, the cDNA coding catalytic domain (T800) and full-length ectodomain (T1300) of TACE were amplified by RT-PCR, and the expression plasmids were constructed by inserting T800 and T1300 into plasmid pET-28a and pET-28c respectively. The recombinant T800 and T1300 were induced by IPTG, and SDS-PAGE and Western blotting analysis results revealed that T800 and T1300 were highly expressed in the form of inclusion body. After Ni super(2+)-NTA resin affinity chromatography, the recombinant proteins were used in the screening of TACE-binding peptides from phage display peptide library respectively. After 4 rounds of biopanning, the positive phage clones were analyzed by ELISA, competitive inhibition assay and DNA sequencing. A common amino acid sequence (TRWLVYFSR-PYLVAT) was found and synthesized. The synthetic peptide could inhibit the TNF- alpha release from LPS-stimulated human peripheral blood mononuclear cells (PBMC) up to 60.3%. FACS analysis revealed that the peptide mediated the accumulation of TNF- alpha on the cell surface. These results demonstrate that the TACE-binding peptide is an effective antagonist of TACE. |
Author | 黄巍 李凌波 韩玲 杨渝珍 |
AuthorAffiliation | Department of Biochemistry & Molecular Biology, School of Basic Medical Sciences, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China Wuhan Institute of Medical Sciences, Wuhan 430014 , China |
AuthorAffiliation_xml | – name: Department of Biochemistry & Molecular Biology, School of Basic Medical Sciences, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China;Wuhan Institute of Medical Sciences,Wuhan 430014,China%Department of Biochemistry & Molecular Biology, School of Basic Medical Sciences, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China |
Author_xml | – sequence: 1 fullname: 黄巍 李凌波 韩玲 杨渝珍 |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/16463648$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kVtrGzEQhUVJaC7tS39AWfqQQsq2uq129Zg6VzA00PRZSKuRLWctOdKaxv--CnZTKCHoYfTwzZk5c47QXogBEPpA8FeCcfvt-yWmnWykJG_QIZGS1YQ1dK_8RUtr3DJ2gI5yXmDctILyt-iACC6Y4N0huvrZJ4Dgw6yKrro7m1xUt7AavYXqJsy98WNMuXIpLqvbuZ5Bde7zatCbZ2rqTdJp8w7tOz1keL-rx-jX5cXd5Lqe_ri6mZxN657KhtTGWqOpLksKhntDW9lQ11mqnZGWc2xBSt6BEB1pO8f7xmHbdbYDCwyYxewYfdnq_tbB6TBTi7hOoUxU42Jzbx8fjQJajJaHSaE_b-lVig9ryKNa-tzDMOgAcZ1VOY2ULcOykCevkkRyyYl4kvy4A9dmCVatkl8W_-rvSQuAt0CfYs4JnOr9qEcfw5i0HxTB6ik19S-10nL6X8uz6kvwpx08j2H2UJJTRvf3zg-gaLEtSFnkD9l6n8k |
CitedBy_id | crossref_primary_10_3390_ijms10125442 |
Cites_doi | 10.4049/jimmunol.159.9.4524 10.1016/0076-6879(93)17065-D 10.1074/jbc.275.19.14608 10.1016/S0014-5793(03)01159-1 10.1038/385733a0 10.1038/385729a0 |
ClassificationCodes | R4 |
ContentType | Journal Article |
Copyright | Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
Copyright_xml | – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
DBID | 2RA 92L CQIGP W91 ~WA AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QO 8FD FR3 P64 7X8 2B. 4A8 92I 93N PSX TCJ |
DOI | 10.1007/BF02895991 |
DatabaseName | 维普期刊资源整合服务平台 中文科技期刊数据库-CALIS站点 维普中文期刊数据库 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Biotechnology Research Abstracts Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic Wanfang Data Journals - Hong Kong WANFANG Data Centre Wanfang Data Journals 万方数据期刊 - 香港版 China Online Journals (COJ) China Online Journals (COJ) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Engineering Research Database Biotechnology Research Abstracts Technology Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic Engineering Research Database |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
DocumentTitleAlternate | Screening of TACE Peptide Inhibitors from Phage Display Peptide Library |
EISSN | 1993-1352 |
EndPage | 476 |
ExternalDocumentID | tjykdxxb_e200505001 16463648 10_1007_BF02895991 20506146 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: The National Natural Sciences Foundation of China; 湖北省卫生厅科研项目 funderid: (30070722); (JX1B098) |
GroupedDBID | -5E -5G -BR -Y2 -~C .86 .VR 06C 06D 0R~ 0VY 1N0 29K 29~ 2B. 2C~ 2J2 2JN 2KG 2KM 2LR 2RA 2~H 30V 4.4 408 40D 40E 53G 5GY 5VS 6NX 8TC 8UJ 92F 92I 92L 95- 95. 95~ 96X AAAVM AABHQ AAJKR AANXM AARHV AARTL AAYIU AAYQN AAYTO ABFTV ABJOX ABKCH ABMNI ABNWP ABQBU ABTMW ACGFS ACHXU ACKNC ACOMO ACSNA ACUDM ADHIR ADINQ ADKPE ADURQ ADYFF ADZKW AEBTG AEGNC AEJHL AEKMD AEOHA AEPYU AETLH AEXYK AFWTZ AFZKB AGAYW AGDGC AGQMX AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHYZX AIIXL AJBLW AJRNO ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP ARMRJ AZFZN B-. BA0 BGNMA CAG CCEZO CHBEP CIEJG COF CQIGP CS3 CSCUP CW9 D-I EBS EJD ESBYG FA0 FEDTE FNLPD FRRFC FWDCC G-Y G-Z GGCAI GGRSB GJIRD GQ6 GQ7 H13 HF~ HG6 HMJXF HRMNR HVGLF HZ~ IJ- IPNFZ IXD I~X I~Z J-C JBSCW JUIAU KOV M4Y MA- N2Q NDZJH NQJWS NU0 O9- O93 O9I O9J P9S PF0 QOR QOS R-E R89 R9I RIG ROL RPX RSV S.. S16 S1Z S27 S37 S3B SAP SCL SDH SHX SMD SNE SNX SOJ SPISZ SZ9 SZN T13 TCJ TGQ TSG TT1 TUC U2A U9L UG4 VC2 W48 W91 WK8 Z7U Z82 Z8V ZOVNA ~A9 ~WA AAYXX ABJNI ABQSL ADHKG AGQPQ CITATION DPUIP CGR CUY CVF ECM EIF NPM 7QO 8FD FR3 P64 7X8 4A8 93N PSX |
ID | FETCH-LOGICAL-c2951-bddba2a199630cb27952f8d2afb9d440de9948e668178f4c5f0d88d8ede3e3d03 |
ISSN | 1672-0733 |
IngestDate | Thu May 29 04:06:47 EDT 2025 Fri Jul 11 15:17:51 EDT 2025 Fri Jul 11 05:52:01 EDT 2025 Thu Jan 02 21:59:41 EST 2025 Tue Aug 05 11:58:52 EDT 2025 Thu Apr 24 22:55:48 EDT 2025 Fri Nov 25 19:17:14 EST 2022 |
IsPeerReviewed | false |
IsScholarly | false |
Issue | 5 |
Keywords | tumor necrosis factor-α converting enzyme phage display ectodomain prokaryote expression peptide inhibitor |
Language | English |
License | http://www.springer.com/tdm |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c2951-bddba2a199630cb27952f8d2afb9d440de9948e668178f4c5f0d88d8ede3e3d03 |
Notes | tumor necrosis factor-α converting enzyme R978.1 tumor necrosis factor-α converting enzyme; ectodomain; prokaryote expression; phage display; peptide inhibitor 42-1679/R phage display ectodomain prokaryote expression peptide inhibitor ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
PMID | 16463648 |
PQID | 19494161 |
PQPubID | 23462 |
PageCount | 4 |
ParticipantIDs | wanfang_journals_tjykdxxb_e200505001 proquest_miscellaneous_733997309 proquest_miscellaneous_19494161 pubmed_primary_16463648 crossref_citationtrail_10_1007_BF02895991 crossref_primary_10_1007_BF02895991 chongqing_backfile_20506146 |
PublicationCentury | 2000 |
PublicationDate | 2005-00-00 |
PublicationDateYYYYMMDD | 2005-01-01 |
PublicationDate_xml | – year: 2005 text: 2005-00-00 |
PublicationDecade | 2000 |
PublicationPlace | China |
PublicationPlace_xml | – name: China |
PublicationTitle | Journal of Huazhong University of Science and Technology. Medical sciences |
PublicationTitleAlternate | Journal of Zuazhong University of Science and Technology: Medical Edition |
PublicationTitle_FL | JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY(MEDICAL SCIENCES) |
PublicationYear | 2005 |
Publisher | Department of Biochemistry & Molecular Biology, School of Basic Medical Sciences, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China Wuhan Institute of Medical Sciences,Wuhan 430014,China%Department of Biochemistry & Molecular Biology, School of Basic Medical Sciences, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China |
Publisher_xml | – name: Wuhan Institute of Medical Sciences,Wuhan 430014,China%Department of Biochemistry & Molecular Biology, School of Basic Medical Sciences, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China – name: Department of Biochemistry & Molecular Biology, School of Basic Medical Sciences, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China |
References | R A Black (BF02895991_CR1) 1997; 385 M L Moss (BF02895991_CR2) 1997; 385 P Reddy (BF02895991_CR7) 2000; 275 K A Solomon (BF02895991_CR6) 1997; 159 N Srour (BF02895991_CR3) 2003; 554 K L Zhu (BF02895991_CR4) 2003; 19 G P Smith (BF02895991_CR5) 1993; 217 9034191 - Nature. 1997 Feb 20;385(6618):733-6 9379053 - J Immunol. 1997 Nov 1;159(9):4524-31 9034190 - Nature. 1997 Feb 20;385(6618):729-33 14623079 - FEBS Lett. 2003 Nov 20;554(3):275-83 10799547 - J Biol Chem. 2000 May 12;275(19):14608-14 7682645 - Methods Enzymol. 1993;217:228-57 |
References_xml | – volume: 19 start-page: 752 issue: 11 year: 2003 ident: BF02895991_CR4 publication-title: Chin J Immunol (Chinese) – volume: 159 start-page: 4524 year: 1997 ident: BF02895991_CR6 publication-title: J Immunol doi: 10.4049/jimmunol.159.9.4524 – volume: 217 start-page: 228 year: 1993 ident: BF02895991_CR5 publication-title: Method Enzymol doi: 10.1016/0076-6879(93)17065-D – volume: 275 start-page: 14608 issue: 19 year: 2000 ident: BF02895991_CR7 publication-title: J Biol Chem doi: 10.1074/jbc.275.19.14608 – volume: 554 start-page: 275 issue: 3 year: 2003 ident: BF02895991_CR3 publication-title: FEBS Lett doi: 10.1016/S0014-5793(03)01159-1 – volume: 385 start-page: 733 issue: 6618 year: 1997 ident: BF02895991_CR2 publication-title: Nature doi: 10.1038/385733a0 – volume: 385 start-page: 729 issue: 6618 year: 1997 ident: BF02895991_CR1 publication-title: Nature doi: 10.1038/385729a0 – reference: 9034190 - Nature. 1997 Feb 20;385(6618):729-33 – reference: 14623079 - FEBS Lett. 2003 Nov 20;554(3):275-83 – reference: 7682645 - Methods Enzymol. 1993;217:228-57 – reference: 10799547 - J Biol Chem. 2000 May 12;275(19):14608-14 – reference: 9034191 - Nature. 1997 Feb 20;385(6618):733-6 – reference: 9379053 - J Immunol. 1997 Nov 1;159(9):4524-31 |
SSID | ssj0057624 |
Score | 1.3655401 |
Snippet | Summary: To obtain the recombinant tumor necrosis factor-α converting enzyme (TACE) ectodomain and use it as a selective molecule for the screening of TACE... To obtain the recombinant tumor necrosis factor-alpha converting enzyme (TACE) ectodomain and use it as a selective molecule for the screening of TACE peptide... To obtain the recombinant tumor necrosis factor- alpha converting enzyme (TACE) ectodomain and use it as a selective molecule for the screening of TACE peptide... R4; To obtain the recombinant tumor necrosis factor-α converting enzyme (TACE) ectodomain and use it as a selective molecule for the screening of TACE peptide... |
SourceID | wanfang proquest pubmed crossref chongqing |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 473 |
SubjectTerms | ADAM Proteins - antagonists & inhibitors ADAM Proteins - biosynthesis ADAM Proteins - genetics ADAM17 Protein Catalytic Domain Escherichia coli - genetics Escherichia coli - metabolism Genetic Vectors - genetics Humans Leukocytes, Mononuclear - cytology Peptide Library Peptides - chemistry Peptides - pharmacology Prokaryotic Cells - metabolism Recombinant Proteins - biosynthesis Recombinant Proteins - genetics Tumor Necrosis Factor-alpha - antagonists & inhibitors 图书馆 外周血 抗生素 缩氨酸 肿瘤坏死因子-α转化酶 |
Title | Screening of TACE Peptide Inhibitors from Phage Display Peptide Library |
URI | http://lib.cqvip.com/qk/85740A/20055/20506146.html https://www.ncbi.nlm.nih.gov/pubmed/16463648 https://www.proquest.com/docview/19494161 https://www.proquest.com/docview/733997309 https://d.wanfangdata.com.cn/periodical/tjykdxxb-e200505001 |
Volume | 25 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfKeOEFgfgK2yASe0EoU-I4H36spo6CxnggFeUpsmObhk1poa209a_nLnGSVtvEx0tUWa6T3v16Pl9-d0fIUShMkmrOvEL6icdCkXoiNLEXq4QZLo0SAnOHP53H4wn7OI2mg8GHLdbSeiWPi82teSX_o1UYA71iluw_aLZbFAbgM-gXrqBhuP6Vjr8UyJqxvOVseDJ6t0CSisJCILNSlnUnnTqBZDFDbo4ql4tLcd3NsiGcOxzU8VpsZtiKaJe80VoDjLj3gfnj7pWP3VOXPWBsSPqrLjv6T2njAd_lvLeBVTvYmSL7zW_rzcymrLUBimjLmsYJUlubShetuaXRFqyiLdvJmp4mN2y63zLV4WwY8aa3127h7PPP-enk7CzPRtPsHrlPkyRAdueEDttNGU5VTX_j9ol2K9XalbG-Bsr1J_zSXT_lxuGjzvGqDIhhyx3JHpGHVk3usAHFYzLQ1RPyvgOEOzcuAsK1qnZ7QLgICLcGhGsB0c2ygHhKJqej7GTs2U4ZXkHBRfakUlJQgYzy0C8kTXhETaqoMJIrxnylOWepjuM0SFLDisj4Kk1VqpUOdaj88BnZq-aVfkFccC-Nr4soTGjBhAgkDWIFxwJcVoNz7pD9TkbgaRUXWD8sp36EoYXYIW9bqeWFLTKPvU4u87Y8di9th7zp5i6a0iq3znrdCj8Hy4evs0Sl5-tlHnDG8XjuEPeOGaBnzmEL4w553qitv1GMlfJY6pAjq8fc_rGX-erH9YW6upK5pnWjR_DkXv75HvvkQV3Wtw7PHZC91a-1PgSHdSVf1VD8DWJhmLg |
linkProvider | Springer Nature |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Screening+of+TACE+peptide+inhibitors+from+phage+display+peptide+library&rft.jtitle=Journal+of+Huazhong+University+of+Science+and+Technology.+Medical+sciences&rft.au=Huang%2C+Wei&rft.au=Li%2C+Lingbo&rft.au=Han%2C+Ling&rft.au=Yang%2C+Yuzhen&rft.date=2005&rft.issn=1672-0733&rft.volume=25&rft.issue=5&rft.spage=473&rft_id=info:doi/10.1007%2FBF02895991&rft.externalDBID=NO_FULL_TEXT |
thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F85740A%2F85740A.jpg http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Ftjykdxxb-e%2Ftjykdxxb-e.jpg |